A Clinical Study on Abhraka Yoga in Management of Madhumeha (Diabetes Mellitus Type -2)

Pharmaceutico-Analytical Study of Abhraka Yoga & Evaluation of its Efficacy in Madhumeha (Diabetes Mellitus Type-2) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071581

Enrollment

Registered

2024-07-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients 30-70 years of both sex will be selected. Patient giving the clinical history of Madhumeha (Diabetes mellitus). Presence of cardinal symptoms of diabetes mellitus e.g. (3P– Polyuria, Polydipsia, Polyphagia) Well Diagnosed and confirmed case of Madhumeha (Diabetes mellitus). Patient fasting blood sugar level is 126mg/dl to 250mg/dl and Post Prandial Blood Sugar (PPBS) level is 200mg/dl to 300mg/dl. Willing to participate and able to provide signed informed consent.

Exclusion criteria

Exclusion criteria: Patients below 30 year and above 70 years will be excluded. Pregnant and lactating mother. Patient having any serious illness like cardiovascular disease, malignancy. Uncontrol Diabetes Mellitus will be excluded from study. Patient of type II DM who are on insulin therapy. Patient having any allergy history or sensitivity will be excluded from study.

Design outcomes

Primary

Measure	Time frame
Efficacy in Madhumeha (Diabetes Mellitus type 2) of Abhrak yogaTimepoint: 90 days	—

Secondary

Measure	Time frame
To Evaluate adverse effect of Abhrak yogaTimepoint: 90 Days	—

Countries

India

Contacts

Public ContactDr Vikas Kumar Baletiya

Post Graduate institute of Ayurved

dr.govindshukla@yahoo.com8769058254

Outcome results